ArticleBreast cancer research and treatment2025

Adverse events in patients treated with neoadjuvant chemo/immunotherapy for triple negative breast cancer: results from seven academic medical centers.

Jessica Mezzanotte-Sharpe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.